期刊文献+

静脉注射丙种球蛋白预防早产儿感染的探讨 被引量:3

A study on intravenous immunoglobulin for preventing infections of premature infants
下载PDF
导出
摘要 目的:为了探讨静脉注射丙种球蛋白(IVIG)预防早产儿感染的价值。方法:用单向免疫琼脂扩散法检测62 例早产儿(胎龄32周~36周)入院时及10 d后的血清IgG、IgM、IgA。同时随机分为IVIG组、抗生素组及对照组,分别 予以IVIG每天按0.5g/kg~1.0 g/kg稀释成50 mL在2h~3h滴完,连用2d;选择青霉素、头孢氨噻肟钠、氧哌嗪青 霉素,使用其中1种~2种.连用3d~5d。结果;IgG均值随胎龄增加而升高(r=0.92,P<0.01),而IgM、IgA差异无 显著意义。且IVIG组治疗后均值明显上升(P<0.01),而抗生素组及对照组较入院时无明显变化(P>0.05);院内感 染发生率为20.97%,其中抗生素组发生率为35.00%,对照组为27.78%,IVIG组仅为4.17 %。结论:静脉注射丙种 球蛋白预防早产儿感染效果满意。 Objective: In order to study the value of intravenous immunogobulin(IVIG) in preventing infections of premature infants. Methods :The serum levels of IgG.IgM and IgA were determined in 62 prematures with single immuno-diffusion thechnique. Meanwhile all cases were divided into IVIG group,antibotic group and control group. Immunogobulin 0. 5-1. 0 g/(kg· d) was given by intravenous infusion within 2-3 hours for two days in IVIG group. All cases of antibiotic group were treated with antibiotics(penicillin,cefotaxime sodium or piperacillin) for 3-5 days. Results: The serum level of IgG increased with the increase of gestational age (GA) (r=0. 92.P<0. 01).but IgM and IgA showed no significant differences. After treatment ,the mean level of IgG rised obviously in IVIG group .while it has no changes of the antibiotic group and control group (P>0. 05). The rate of Nosocomial infections disease was 20. 97% (antibiotic group: 35. 00% ,control group: 27. 78% , IVIG group:4. 17 %). Conclusions: Intravenous im-munogobulin(IVIG) has satisfactory effectiveness for preventing infections of premature infants.
出处 《山西临床医药》 2001年第12期887-888,共2页 Shanxi Clinical Medicine
关键词 丙种球蛋白 早产儿感染 单向免疫琼脂扩散法 早产儿 immunoglobulin prevention infant infection
  • 相关文献

参考文献1

二级参考文献5

  • 1Report of a WHO Scientific Group.Primary immedficency diseases.Clin Exp Immunol,1995,99(Supplement 1 Jan):2.
  • 2Cooley ME 4 Stiehm ER.Immunodeficinecy disoders general cousiderations in immunologic disorders in infents & children 4th Ed by stiehm ER philadelphis Sundrers ,1996,201.
  • 3Cunningham-Rundles C,Kasbay K,Hassetr J et al.Enhanced humoral immunity in CVIED after longterm treatment with PEG-conjugated IL-2 N Engl J Med,1994,331:918.
  • 4Chaffee S,Mary A Stiehm ER,et al.IgG antibody response to PEG-modified ADA in patients with adenosme deammnase deficinecy j Clin Invest ,1992,89:1643.
  • 5许怀琪,林梓,郭履胴,等.静脉输注免疫球蛋白在原发性免疫缺陷病中的应用.人民军医(药学专刊),1995,4期增刊;63.

共引文献5

同被引文献27

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部